JP2021534798A5 - - Google Patents
Info
- Publication number
- JP2021534798A5 JP2021534798A5 JP2021511605A JP2021511605A JP2021534798A5 JP 2021534798 A5 JP2021534798 A5 JP 2021534798A5 JP 2021511605 A JP2021511605 A JP 2021511605A JP 2021511605 A JP2021511605 A JP 2021511605A JP 2021534798 A5 JP2021534798 A5 JP 2021534798A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- polypeptide
- sequence
- domain
- template rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025011363A JP2025063317A (ja) | 2018-08-28 | 2025-01-27 | ゲノムを調節するための方法及び組成物 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862723886P | 2018-08-28 | 2018-08-28 | |
| US62/723,886 | 2018-08-28 | ||
| US201862725778P | 2018-08-31 | 2018-08-31 | |
| US62/725,778 | 2018-08-31 | ||
| US201962850883P | 2019-05-21 | 2019-05-21 | |
| US62/850,883 | 2019-05-21 | ||
| US201962864924P | 2019-06-21 | 2019-06-21 | |
| US62/864,924 | 2019-06-21 | ||
| PCT/US2019/048607 WO2020047124A1 (en) | 2018-08-28 | 2019-08-28 | Methods and compositions for modulating a genome |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025011363A Division JP2025063317A (ja) | 2018-08-28 | 2025-01-27 | ゲノムを調節するための方法及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021534798A JP2021534798A (ja) | 2021-12-16 |
| JP2021534798A5 true JP2021534798A5 (enExample) | 2022-09-06 |
| JP7680351B2 JP7680351B2 (ja) | 2025-05-20 |
Family
ID=67997683
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511605A Active JP7680351B2 (ja) | 2018-08-28 | 2019-08-28 | ゲノムを調節するための方法及び組成物 |
| JP2025011363A Pending JP2025063317A (ja) | 2018-08-28 | 2025-01-27 | ゲノムを調節するための方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025011363A Pending JP2025063317A (ja) | 2018-08-28 | 2025-01-27 | ゲノムを調節するための方法及び組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US12031129B2 (enExample) |
| EP (1) | EP3844272A1 (enExample) |
| JP (2) | JP7680351B2 (enExample) |
| KR (1) | KR20210049859A (enExample) |
| CN (1) | CN113286880A (enExample) |
| AU (2) | AU2019327449B2 (enExample) |
| BR (1) | BR112021003380A2 (enExample) |
| CA (1) | CA3109953A1 (enExample) |
| IL (1) | IL280947A (enExample) |
| WO (1) | WO2020047124A1 (enExample) |
Families Citing this family (117)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013066438A2 (en) | 2011-07-22 | 2013-05-10 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| US20150166984A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| AU2017308889B2 (en) | 2016-08-09 | 2023-11-09 | President And Fellows Of Harvard College | Programmable Cas9-recombinase fusion proteins and uses thereof |
| KR20240007715A (ko) | 2016-10-14 | 2024-01-16 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
| WO2018165504A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| KR20190123328A (ko) | 2017-03-09 | 2019-10-31 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 암 백신 |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| IL306092A (en) | 2017-03-23 | 2023-11-01 | Harvard College | Nucleic base editors that include nucleic acid programmable DNA binding proteins |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| US10011849B1 (en) | 2017-06-23 | 2018-07-03 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| US9982279B1 (en) | 2017-06-23 | 2018-05-29 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| MX2019015505A (es) | 2017-06-30 | 2020-07-28 | Inscripta Inc | Metodos, modulos, instrumentos y sistemas de procesamiento de celulas automatizados. |
| EP3658573A1 (en) | 2017-07-28 | 2020-06-03 | President and Fellows of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| WO2019051097A1 (en) | 2017-09-08 | 2019-03-14 | The Regents Of The University Of California | RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USING SAME |
| CA3082251A1 (en) | 2017-10-16 | 2019-04-25 | The Broad Institute, Inc. | Uses of adenosine base editors |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| US10557216B2 (en) | 2018-04-24 | 2020-02-11 | Inscripta, Inc. | Automated instrumentation for production of T-cell receptor peptide libraries |
| US10858761B2 (en) | 2018-04-24 | 2020-12-08 | Inscripta, Inc. | Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells |
| WO2019226953A1 (en) | 2018-05-23 | 2019-11-28 | The Broad Institute, Inc. | Base editors and uses thereof |
| EP3820495A4 (en) | 2018-07-09 | 2022-07-20 | The Broad Institute Inc. | RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES |
| AU2019327449B2 (en) | 2018-08-28 | 2026-04-09 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| US11001831B2 (en) | 2019-03-25 | 2021-05-11 | Inscripta, Inc. | Simultaneous multiplex genome editing in yeast |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| EP3953477A4 (en) | 2019-06-06 | 2022-06-22 | Inscripta, Inc. | HARDENING FOR RECURSIVE NUCLEIC ACID-DRIVEN CELL EDITING |
| US20220298495A1 (en) * | 2019-06-12 | 2022-09-22 | Emendobio Inc. | Novel genome editing tool |
| US20220259617A1 (en) | 2019-06-13 | 2022-08-18 | The General Hospital Corporation | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells |
| WO2021046243A2 (en) * | 2019-09-03 | 2021-03-11 | Myeloid Therapeutics, Inc. | Methods and compositions for genomic integration |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| US20230040216A1 (en) * | 2019-11-19 | 2023-02-09 | The Broad Institute, Inc. | Retrotransposons and use thereof |
| US11203762B2 (en) | 2019-11-19 | 2021-12-21 | Inscripta, Inc. | Methods for increasing observed editing in bacteria |
| WO2021126886A1 (en) | 2019-12-18 | 2021-06-24 | Inscripta, Inc. | Cascade/dcas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells |
| BR112022017715A2 (pt) * | 2020-03-04 | 2022-11-16 | Flagship Pioneering Innovations Vi Llc | Métodos e composições para modular um genoma |
| IL296095A (en) | 2020-03-04 | 2022-11-01 | Flagship Pioneering Innovations Vi Llc | Improved methods and compositions for genome modulation |
| AU2021232005A1 (en) * | 2020-03-04 | 2022-09-29 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
| BR112022017735A2 (pt) * | 2020-03-05 | 2022-11-29 | Flagship Pioneering Innovations Vi Llc | Métodos e composições de supressão de defesa de hospedeiro para modular um genoma |
| WO2021188840A1 (en) * | 2020-03-19 | 2021-09-23 | Rewrite Therapeutics, Inc. | Methods and compositions for directed genome editing |
| CN115427566A (zh) * | 2020-04-08 | 2022-12-02 | 阿斯利康(瑞典)有限公司 | 用于改善的位点特异性修饰的组合物和方法 |
| US20210332388A1 (en) | 2020-04-24 | 2021-10-28 | Inscripta, Inc. | Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells |
| CA3177481A1 (en) | 2020-05-08 | 2021-11-11 | David R. Liu | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| WO2021248102A1 (en) * | 2020-06-05 | 2021-12-09 | Flagship Pioneering Innovations Vi, Llc | Template guide rna molecules |
| BR112023001272A2 (pt) | 2020-07-24 | 2023-04-04 | Massachusetts Gen Hospital | Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células |
| EP4214314A4 (en) | 2020-09-15 | 2024-10-16 | Inscripta, Inc. | Crispr editing to embed nucleic acid landing pads into genomes of live cells |
| KR20230091894A (ko) | 2020-10-21 | 2023-06-23 | 메사추세츠 인스티튜트 오브 테크놀로지 | 부위 특이적 표적화 요소를 통한 프로그램 가능한 첨가(paste)를 사용하는 부위 특이적 유전 공학을 위한 시스템, 방법, 및 조성물 |
| WO2022125329A1 (en) * | 2020-12-07 | 2022-06-16 | Inscripta, Inc. | gRNA STABILIZATION IN NUCLEIC ACID-GUIDED NICKASE EDITING |
| CA3204158A1 (en) | 2021-01-04 | 2022-07-07 | Juhan Kim | Mad nucleases |
| CN116745428A (zh) * | 2021-01-14 | 2023-09-12 | 加利福尼亚大学董事会 | 位点特异性基因修饰 |
| CN112708636A (zh) * | 2021-01-22 | 2021-04-27 | 彭双红 | 基因转录框架、载体系统、基因组序列编辑方法及应用 |
| US20240132916A1 (en) * | 2021-02-09 | 2024-04-25 | The Broad Institute, Inc. | Nuclease-guided non-ltr retrotransposons and uses thereof |
| US11884924B2 (en) | 2021-02-16 | 2024-01-30 | Inscripta, Inc. | Dual strand nucleic acid-guided nickase editing |
| WO2022183210A1 (en) * | 2021-02-26 | 2022-09-01 | Flagship Pioneering Innovations Vi, Llc | Tissue-specific methods and compositions for modulating a genome |
| AU2022240747A1 (en) * | 2021-03-19 | 2023-10-05 | Flagship Pioneering Innovations Vi, Llc | Ltr transposon compositions and methods |
| AR125216A1 (es) | 2021-03-26 | 2023-06-28 | Flagship Pioneering Innovations Vii Llc | Producción de polirribonucleótidos circulares en un sistema eucariota |
| US20250188505A1 (en) | 2021-03-26 | 2025-06-12 | Flagship Pioneering Innovations Vii, Llc | Production of circular polyribonucleotides in a prokaryotic system |
| TW202300650A (zh) | 2021-03-26 | 2023-01-01 | 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 | 真核系統中環狀多核糖核苷酸的產生 |
| WO2022241029A1 (en) | 2021-05-11 | 2022-11-17 | Myeloid Therapeutics, Inc. | Methods and compositions for genomic integration |
| AU2022315304A1 (en) | 2021-07-23 | 2024-02-08 | Flagship Pioneering Innovations Vii, Llc | Compositions for fungal control and related methods |
| CA3231712A1 (en) | 2021-09-08 | 2023-03-16 | Flagship Pioneering Innovations Vi, Llc | Pah-modulating compositions and methods |
| KR20260037664A (ko) | 2021-09-08 | 2026-03-18 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | 게놈을 조절하기 위한 방법 및 조성물 |
| CN118119704A (zh) * | 2021-09-08 | 2024-05-31 | 宏基因组学公司 | 用于转座货物核苷酸序列的系统和方法 |
| KR20240051994A (ko) * | 2021-09-08 | 2024-04-22 | 메타지노미, 인크. | 레트로트랜스포존 및 이의 기능적 단편을 포함하는 시스템, 조성물, 및 방법 |
| AR127073A1 (es) | 2021-09-17 | 2023-12-13 | Flagship Pioneering Innovations Vi Llc | Composiciones y métodos para producir polirribonucleótidos circulares |
| EP4419706A1 (en) | 2021-10-18 | 2024-08-28 | Flagship Pioneering Innovations VI, LLC | Compositions and methods for purifying polyribonucleotides |
| WO2023069972A1 (en) * | 2021-10-19 | 2023-04-27 | Massachusetts Institute Of Technology | Genomic editing with site-specific retrotransposons |
| EP4426828A1 (en) | 2021-11-01 | 2024-09-11 | Tome Biosciences, Inc. | Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo |
| EP4444362A4 (en) | 2021-12-10 | 2026-04-01 | Flagship Pioneering Innovations Vi Llc | CFTR COMPOSITIONS AND MODULATION METHODS |
| US20250057980A1 (en) | 2021-12-22 | 2025-02-20 | Tome Biosciences, Inc. | Co-Delivery of a Gene Editor Construct and a Donor Template |
| EP4453201A1 (en) | 2021-12-22 | 2024-10-30 | Flagship Pioneering Innovations VI, LLC | Compositions and methods for purifying polyribonucleotides |
| WO2023205744A1 (en) | 2022-04-20 | 2023-10-26 | Tome Biosciences, Inc. | Programmable gene insertion compositions |
| WO2023215727A2 (en) * | 2022-05-02 | 2023-11-09 | The Regents Of The University Of California | Multicomponent systems for site-specific genome modifications |
| WO2023215831A1 (en) | 2022-05-04 | 2023-11-09 | Tome Biosciences, Inc. | Guide rna compositions for programmable gene insertion |
| WO2023225670A2 (en) | 2022-05-20 | 2023-11-23 | Tome Biosciences, Inc. | Ex vivo programmable gene insertion |
| KR20250019772A (ko) | 2022-05-25 | 2025-02-11 | 플래그쉽 파이어니어링 이노베이션스 Vii, 엘엘씨 | 종양 억제인자 및 발암유전자를 조절하기 위한 조성물 및 방법 |
| AU2023275550A1 (en) | 2022-05-25 | 2024-11-21 | Flagship Pioneering Innovations Vii, Llc | Compositions and methods for modulating cytokines |
| CN119563038A (zh) | 2022-05-25 | 2025-03-04 | 旗舰创业创新七公司 | 用于调节免疫应答的组合物和方法 |
| EP4531879A1 (en) | 2022-05-25 | 2025-04-09 | Flagship Pioneering Innovations VI, LLC | Compositions of secretory and/or catalytic cells and methods using the same |
| AU2023277636A1 (en) | 2022-05-25 | 2024-11-21 | Flagship Pioneering Innovations Vii, Llc | Compositions and methods for modulating genetic drivers |
| EP4650780A3 (en) | 2022-05-25 | 2026-01-21 | Flagship Pioneering Innovations VII, LLC | Compositions and methods for modulating circulating factors |
| JP2025525569A (ja) | 2022-07-18 | 2025-08-05 | レナゲード セラピューティクス マネージメント インコーポレイテッド | 遺伝子編集成分、システム、及び使用方法 |
| WO2024020587A2 (en) | 2022-07-22 | 2024-01-25 | Tome Biosciences, Inc. | Pleiopluripotent stem cell programmable gene insertion |
| WO2024086586A2 (en) * | 2022-10-18 | 2024-04-25 | Flagship Pioneering Innovations Vi, Llc | Improved gene editing systems utilizing trans recruiting components |
| EP4612296A1 (en) | 2022-10-31 | 2025-09-10 | Flagship Pioneering Innovations VI, LLC | Compositions and methods for purifying polyribonucleotides |
| WO2024102799A1 (en) | 2022-11-08 | 2024-05-16 | Flagship Pioneering Innovations Vi, Llc | Compositions and methods for producing circular polyribonucleotides |
| JP2026500188A (ja) * | 2022-12-09 | 2026-01-06 | メタゲノミ，インク． | レトロトランスポゾン組成物および使用方法 |
| WO2024131786A1 (zh) * | 2022-12-19 | 2024-06-27 | 北京干细胞与再生医学研究院 | 一种在基因组插入大片段dna的系统 |
| WO2024138194A1 (en) | 2022-12-22 | 2024-06-27 | Tome Biosciences, Inc. | Platforms, compositions, and methods for in vivo programmable gene insertion |
| CN120958034A (zh) | 2023-02-23 | 2025-11-14 | 微肽技术有限公司 | 用于产生和纯化肽的方法和组合物 |
| EP4680276A1 (en) | 2023-03-15 | 2026-01-21 | Flagship Pioneering Innovations VI, LLC | Immunogenic compositions and uses thereof |
| EP4680750A1 (en) | 2023-03-15 | 2026-01-21 | Flagship Pioneering Innovations VI, LLC | Compositions comprising polyribonucleotides and uses thereof |
| JP2026514069A (ja) * | 2023-04-11 | 2026-05-01 | ベイジン・アストラジェノミクス・テクノロジー・カンパニー，リミテッド | 非ｌｔｒレトロトランスポゾンシステム及びその使用 |
| WO2024218715A1 (en) | 2023-04-19 | 2024-10-24 | Btl Healthcare Technologies A.S. | Culture media based on protein hydrolysate and a process for preparing thereof |
| WO2024220741A1 (en) | 2023-04-19 | 2024-10-24 | Flagship Pioneering Innovations Vii, Llc | Compositions and methods for the production of libraries |
| WO2024234006A1 (en) | 2023-05-11 | 2024-11-14 | Tome Biosciences, Inc. | Systems, compositions, and methods for targeting liver sinusodial endothelial cells (lsecs) |
| WO2025006419A1 (en) | 2023-06-26 | 2025-01-02 | Flagship Pioneering Innovations Vii, Llc | Engineered plasmodia and related methods |
| CN121358858A (zh) * | 2023-07-10 | 2026-01-16 | 北京干细胞与再生医学研究院 | 工程化的哺乳动物基因写入系统 |
| CN121712890A (zh) * | 2023-08-16 | 2026-03-20 | 基础科学研究院 | 使用具有单链断裂活性的CRISPR/Cas系统和PARP抑制剂的细胞死亡方法 |
| EP4771154A2 (en) | 2023-09-01 | 2026-07-08 | Renagade Therapeutics Management Inc. | Gene editing systems, compositions, and methods for treatment of vexas syndrome |
| WO2025050069A1 (en) | 2023-09-01 | 2025-03-06 | Tome Biosciences, Inc. | Programmable gene insertion using engineered integration enzymes |
| US12668774B2 (en) | 2023-10-12 | 2026-06-30 | Btl Healthcare Technologies A.S. | Product, system and method of cell cultivation |
| AU2024361969A1 (en) * | 2023-10-16 | 2026-04-23 | The University Of Tokyo | R2 retrotransposons for gene writing |
| WO2025128545A1 (en) * | 2023-12-11 | 2025-06-19 | Aera Therapeutics, Inc. | Engineered mobile genetic element systems |
| WO2025128871A2 (en) | 2023-12-13 | 2025-06-19 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| WO2025132815A1 (en) | 2023-12-20 | 2025-06-26 | Novozymes A/S | Novel cas nucleases and polynucleotides encoding the same |
| WO2025155753A2 (en) | 2024-01-17 | 2025-07-24 | Renagade Therapeutics Management Inc. | Improved gene editing system, guides, and methods |
| WO2025174765A1 (en) | 2024-02-12 | 2025-08-21 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| WO2025217194A1 (en) * | 2024-04-09 | 2025-10-16 | Typewriter Therapeutics, Inc. | Repeat dosing of retrotransposons |
| WO2025224182A2 (en) | 2024-04-23 | 2025-10-30 | Basecamp Research Ltd | Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo |
| WO2026062521A2 (en) | 2024-09-18 | 2026-03-26 | Institute Of Molecular And Clinical Ophthalmology Basel (Iob) | Methods and compounds for promoting survival of photoreceptors |
| WO2026132030A1 (en) | 2024-12-19 | 2026-06-25 | Novozymes A/S | Cas nucleases and polynucleotides encoding the same |
| WO2026148005A1 (en) | 2025-01-03 | 2026-07-09 | Sail Biomedicines, Inc. | Compositions and methods for purifying polyribonucleotides |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030121063A1 (en) | 1995-11-16 | 2003-06-26 | The Trustees Of The University Of Pennsylvania | Compositions and methods of use of mammalian retrotransposons |
| US6693086B1 (en) | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| CN1342758A (zh) * | 2000-09-12 | 2002-04-03 | 上海博德基因开发有限公司 | 一种新的多肽——逆转录酶9.24和编码这种多肽的多核苷酸 |
| JP2002291473A (ja) * | 2001-04-02 | 2002-10-08 | New Industry Research Organization | レトロトランスポゾン、プロモーター活性を有するｄｎａ断片、及びその利用 |
| US20060183226A1 (en) * | 2002-01-31 | 2006-08-17 | Haruhiko Fujiwara | Methods for retrotransposing long interspersed elements (lines) |
| US20070037759A1 (en) | 2003-02-07 | 2007-02-15 | Administrators Of The Tulane Educational Fund, The | Mammalian retrotransposable elements |
| EP1636343B1 (en) * | 2003-05-28 | 2013-08-21 | The Johns-Hopkins University | Synthetic mammalian retrotransposon gene |
| US20080104723A1 (en) * | 2003-11-21 | 2008-05-01 | Osaka Industrial Promojtion Organization C/O Mydom | Development of Mammalian Genome Modification Technique Using Retrotransposon |
| MX2007014139A (es) * | 2005-05-14 | 2008-10-09 | Univ Fudan | Piggybac como una herramienta para manipulacion genetica y analisis en vertebrados. |
| WO2007130543A2 (en) | 2006-05-04 | 2007-11-15 | Abmaxis Inc. | Method for producing stable mammalian cell lines producing high levels of recombinant proteins |
| US8598328B2 (en) * | 2006-12-13 | 2013-12-03 | National University Corporation Nagoya University | Tol1 factor transposase and DNA introduction system using the same |
| EP2055784A1 (en) | 2007-10-31 | 2009-05-06 | Bundesrepublik Deutschland, letztvertreten durch den Präsidenten des Paul-Ehrlich-Instituts Prof. Dr. Johannes Löwer | Controlled activation of non-LTR retrotransposons in mammals |
| US8889394B2 (en) | 2009-09-07 | 2014-11-18 | Empire Technology Development Llc | Multiple domain proteins |
| AU2010325563B2 (en) | 2009-11-27 | 2017-02-02 | Basf Plant Science Company Gmbh | Chimeric endonucleases and uses thereof |
| KR101911969B1 (ko) * | 2011-02-23 | 2018-10-25 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | Ｄｎａ 합성을 위한 주형 스위칭의 용도 |
| US20140113375A1 (en) | 2012-10-21 | 2014-04-24 | Lixin Liu | Transient Expression And Reverse Transcription Aided Genome Alteration System |
| EP3064585B1 (en) | 2012-12-12 | 2020-02-05 | The Broad Institute, Inc. | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation |
| CN105209621B (zh) | 2012-12-12 | 2021-05-25 | 布罗德研究所有限公司 | 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化 |
| ES2749624T3 (es) | 2013-03-14 | 2020-03-23 | Caribou Biosciences Inc | Composiciones y métodos de ácidos nucleicos dirigidos a ácido nucleico |
| US20140349400A1 (en) | 2013-03-15 | 2014-11-27 | Massachusetts Institute Of Technology | Programmable Modification of DNA |
| DK3456831T3 (da) * | 2013-04-16 | 2021-09-06 | Regeneron Pharma | Målrettet modifikation af rottegenom |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| WO2015191693A2 (en) | 2014-06-10 | 2015-12-17 | Massachusetts Institute Of Technology | Method for gene editing |
| WO2016028843A2 (en) | 2014-08-19 | 2016-02-25 | President And Fellows Of Harvard College | Rna-guided systems for probing and mapping of nucleic acids |
| WO2016036754A1 (en) | 2014-09-02 | 2016-03-10 | The Regents Of The University Of California | Methods and compositions for rna-directed target dna modification |
| WO2016065364A1 (en) | 2014-10-24 | 2016-04-28 | Life Technologies Corporation | Compositions and methods for enhancing homologous recombination |
| EP3221457B1 (en) * | 2014-11-21 | 2019-03-20 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for targeted genetic modification using paired guide rnas |
| US11911415B2 (en) | 2015-06-09 | 2024-02-27 | Editas Medicine, Inc. | CRISPR/Cas-related methods and compositions for improving transplantation |
| WO2016205728A1 (en) | 2015-06-17 | 2016-12-22 | Massachusetts Institute Of Technology | Crispr mediated recording of cellular events |
| WO2017059241A1 (en) | 2015-10-02 | 2017-04-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Lentiviral protein delivery system for rna-guided genome editing |
| WO2017123609A1 (en) | 2016-01-12 | 2017-07-20 | The Regents Of The University Of California | Compositions and methods for enhanced genome editing |
| GB201602473D0 (en) * | 2016-02-11 | 2016-03-30 | Horizon Discovery Ltd | Replicative transposon system |
| US20170275665A1 (en) | 2016-02-24 | 2017-09-28 | Board Of Regents, The University Of Texas System | Direct crispr spacer acquisition from rna by a reverse-transcriptase-cas1 fusion protein |
| US11447768B2 (en) | 2016-03-01 | 2022-09-20 | University Of Florida Research Foundation, Incorporated | Molecular cell diary system |
| ES3030658T3 (en) * | 2016-03-30 | 2025-07-01 | Intellia Therapeutics Inc | Lipid nanoparticle formulations for crispr/cas components |
| WO2017173004A1 (en) * | 2016-03-30 | 2017-10-05 | Mikuni Takayasu | A method for in vivo precise genome editing |
| WO2017180711A1 (en) | 2016-04-13 | 2017-10-19 | Editas Medicine, Inc. | Grna fusion molecules, gene editing systems, and methods of use thereof |
| KR102370675B1 (ko) | 2016-04-29 | 2022-03-04 | 바스프 플랜트 사이언스 컴퍼니 게엠베하 | 표적 핵산의 변형을 위한 개선된 방법 |
| WO2017197238A1 (en) | 2016-05-12 | 2017-11-16 | President And Fellows Of Harvard College | Aav split cas9 genome editing and transcriptional regulation |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| WO2018045321A1 (en) | 2016-09-02 | 2018-03-08 | North Carolina State University | Methods and compositions for modification of plastid genomes |
| EP4431607A3 (en) | 2016-09-09 | 2024-12-11 | The Board of Trustees of the Leland Stanford Junior University | High-throughput precision genome editing |
| US20190330620A1 (en) | 2016-10-14 | 2019-10-31 | Emendobio Inc. | Rna compositions for genome editing |
| WO2018089860A1 (en) | 2016-11-11 | 2018-05-17 | 2D Genomics Inc. | Methods for processing nucleic acid samples |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| IL306092A (en) | 2017-03-23 | 2023-11-01 | Harvard College | Nucleic base editors that include nucleic acid programmable DNA binding proteins |
| CA3063733A1 (en) | 2017-05-25 | 2018-11-29 | The General Hospital Corporation | Base editors with improved precision and specificity |
| WO2019051097A1 (en) | 2017-09-08 | 2019-03-14 | The Regents Of The University Of California | RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USING SAME |
| JP2021530212A (ja) | 2018-07-13 | 2021-11-11 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California | レトロトランスポゾンベースの送達媒体及びその使用方法 |
| AU2019327449B2 (en) | 2018-08-28 | 2026-04-09 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
| CN117925571A (zh) | 2018-10-19 | 2024-04-26 | 德克萨斯州大学系统董事会 | 工程化长散在元件（line）转座子及其使用方法 |
| US12410429B2 (en) | 2019-03-14 | 2025-09-09 | Cornell University | Compositions and methods for gene targeting using CRISPR-Cas and transposons |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| US20220298495A1 (en) | 2019-06-12 | 2022-09-22 | Emendobio Inc. | Novel genome editing tool |
| CA3147875A1 (en) | 2019-07-19 | 2021-01-28 | Flagship Pioneering Innovations Vi, Llc | Recombinase compositions and methods of use |
| WO2021080922A1 (en) | 2019-10-21 | 2021-04-29 | The Trustees Of Columbia University In The City Of New York | Methods of performing rna templated genome editing |
| EP4061940A4 (en) | 2019-11-22 | 2024-10-23 | Flagship Pioneering Innovations VI, LLC | RECOMBINASE COMPOSITIONS AND METHODS OF USE |
| IL296095A (en) | 2020-03-04 | 2022-11-01 | Flagship Pioneering Innovations Vi Llc | Improved methods and compositions for genome modulation |
| BR112022017715A2 (pt) | 2020-03-04 | 2022-11-16 | Flagship Pioneering Innovations Vi Llc | Métodos e composições para modular um genoma |
| AU2021232005A1 (en) | 2020-03-04 | 2022-09-29 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
| US20230348939A1 (en) | 2020-03-04 | 2023-11-02 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
| BR112022017735A2 (pt) | 2020-03-05 | 2022-11-29 | Flagship Pioneering Innovations Vi Llc | Métodos e composições de supressão de defesa de hospedeiro para modular um genoma |
| WO2021248102A1 (en) | 2020-06-05 | 2021-12-09 | Flagship Pioneering Innovations Vi, Llc | Template guide rna molecules |
| WO2022183210A1 (en) | 2021-02-26 | 2022-09-01 | Flagship Pioneering Innovations Vi, Llc | Tissue-specific methods and compositions for modulating a genome |
| AU2022240747A1 (en) | 2021-03-19 | 2023-10-05 | Flagship Pioneering Innovations Vi, Llc | Ltr transposon compositions and methods |
| EP4347859A4 (en) | 2021-05-26 | 2025-07-02 | Flagship Pioneering Innovations Vi Llc | INTEGRASE COMPOSITIONS AND METHODS |
| WO2023039447A2 (en) | 2021-09-08 | 2023-03-16 | Flagship Pioneering Innovations Vi, Llc | Serpina-modulating compositions and methods |
| CA3231712A1 (en) | 2021-09-08 | 2023-03-16 | Flagship Pioneering Innovations Vi, Llc | Pah-modulating compositions and methods |
| KR20260037664A (ko) | 2021-09-08 | 2026-03-18 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | 게놈을 조절하기 위한 방법 및 조성물 |
| MX2024002930A (es) | 2021-09-08 | 2024-05-29 | Flagship Pioneering Innovations Vi Llc | Metodos y composiciones para modular un genoma. |
| EP4399307A4 (en) | 2021-09-08 | 2026-01-21 | Flagship Pioneering Innovations Vi Llc | HBB COMPOSITIONS AND MODULATION METHODS |
| EP4444362A4 (en) | 2021-12-10 | 2026-04-01 | Flagship Pioneering Innovations Vi Llc | CFTR COMPOSITIONS AND MODULATION METHODS |
-
2019
- 2019-08-28 AU AU2019327449A patent/AU2019327449B2/en active Active
- 2019-08-28 CA CA3109953A patent/CA3109953A1/en active Pending
- 2019-08-28 JP JP2021511605A patent/JP7680351B2/ja active Active
- 2019-08-28 WO PCT/US2019/048607 patent/WO2020047124A1/en not_active Ceased
- 2019-08-28 BR BR112021003380-7A patent/BR112021003380A2/pt not_active Application Discontinuation
- 2019-08-28 CN CN201980069630.5A patent/CN113286880A/zh active Pending
- 2019-08-28 KR KR1020217008540A patent/KR20210049859A/ko active Pending
- 2019-08-28 EP EP19770218.6A patent/EP3844272A1/en active Pending
- 2019-12-06 US US16/706,448 patent/US12031129B2/en active Active
-
2021
- 2021-02-17 IL IL280947A patent/IL280947A/en unknown
-
2024
- 2024-04-01 US US18/623,612 patent/US12398392B2/en active Active
-
2025
- 2025-01-27 JP JP2025011363A patent/JP2025063317A/ja active Pending
- 2025-07-25 US US19/281,203 patent/US20260185085A1/en active Pending
-
2026
- 2026-07-09 AU AU2026205449A patent/AU2026205449A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025063317A5 (enExample) | ||
| Saltarelli et al. | Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus | |
| Russell et al. | Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably? | |
| CA3174483A1 (en) | Improved methods and compositions for modulating a genome | |
| JPH05506997A (ja) | オリゴヌクレオチドによるインフルエンザウィルス複製の阻止 | |
| US20230203137A1 (en) | Preparation method of artificial antibody | |
| JP2017510293A5 (enExample) | ||
| WO2010060967A3 (en) | Compositions and methods for treating retrovirus infections | |
| KR102803306B1 (ko) | 교정 효율이 개선된 프라임에디팅용 조성물 | |
| CA2914550C (en) | Avian cells for improved virus production | |
| JP2009203242A (ja) | インビボ（ｉｎｖｉｖｏ）マルチプルｄｎａワクチンと多価ｄｎａワクチン | |
| Li et al. | Sequence and insertion sites of murine melanoma-associated retrovirus | |
| CN101314775B (zh) | 可用于艾滋病治疗的rna干扰靶点 | |
| RU2018130683A (ru) | Аттенуированный вирус инфекционного бронхита | |
| US20160281089A1 (en) | Prevention of viral infectivity | |
| JP2020503014A5 (enExample) | ||
| Zhao et al. | Analysis of a QX-like avian infectious bronchitis virus genome identified recombination in the region containing the ORF 5a, ORF 5b, and nucleocapsid protein gene sequences | |
| Pérot et al. | From viruses to genes: syncytins | |
| JP2007536891A5 (enExample) | ||
| JPH09502348A (ja) | 遺伝学的に分岐したｈｉｖ−１株に対する中和抗体を誘導するペプチド | |
| TWI670064B (zh) | 抗病毒劑及治療病毒感染之方法 | |
| CN103966259B (zh) | 一种基于J亚群禽白血病病毒gag基因保守序列的siRNA重组干扰载体及其制备方法和应用 | |
| Heinrich et al. | A short hairpin loop-structured oligodeoxynucleotide targeting the virion-associated RNase H of HIV inhibits HIV production in cell culture and in huPBL-SCID mice | |
| CN113274510B (zh) | 抑制j亚群禽白血病病毒复制的组合物及其应用 | |
| JPH09510361A (ja) | パッケージング欠陥性レンチウイルス |